InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEED Insider Trading

Insider Ownership Percentage: 28.04%
Insider Buying (Last 12 Months): £18,150
Insider Selling (Last 12 Months): GBX 0

Seed Innovations Insider Trading History Chart

This chart shows the insider buying and selling history at Seed Innovations by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Seed Innovations Share Price & Price History

Current Price: GBX 2.39
Price Change: ▼ Price Decrease of -0.01 (-0.42%)
As of 11/29/2023 01:00 AM ET

This chart shows the closing price history over time for SEED up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Seed Innovations Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2023Edward (Ed) Peter McDermottInsiderBuy405,000GBX 3£12,150
12/14/2022Ian BurnsInsiderBuy200,000GBX 3£6,000
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Seed Innovations (LON:SEED)

0.03% of Seed Innovations stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Seed Innovations logo
Seed Innovations Limited, is a venture capital firm specializing in early stage investments. The firm prefers to focus on investments in innovative lifestyle, wellness, health, medical cannabis the technology sector and life sciences, medical cannabis and pharmaceuticals. It typically invests in North America and Europe but will consider investments elsewhere in the world. The firm can take a minority position to full ownership in its investments. It considers investments in companies with significant intellectual property rights. Seed Innovations Limited is based in Guernsey, Channel Islands.
Read More on Seed Innovations

Today's Range

Now: GBX 2.39
Low: 2.32
High: 2.44

50 Day Range

MA: GBX 3.05
Low: 2.35
High: 4.10

52 Week Range

Now: GBX 2.39
Low: 1.61
High: 4.43

Volume

672,490 shs

Average Volume

1,401,612 shs

Market Capitalization

£4.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Seed Innovations?

Seed Innovations' top insider shareholders include:
  1. Edward (Ed) Peter McDermott (Insider)
  2. Ian Burns (Insider)
Learn More about top insider investors at Seed Innovations.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.